A Rare Cause of Gastrointestinal Bleeding: Crimean-Congo Haemorrhagic Fever Disease
Journal Title: Journal of Microbiology and Infectious Diseases - Year 2016, Vol 6, Issue 1
Abstract
Crimean-Congo Haemorrhagic Fever (CCHF) disease is a viral haemorrhagic fever syndrome present in Turkey since 2002 [1]. CCHF is transmitted by ticks and can be fatal. Thrombocytopenia and coagulopathy can develop and, because of severe bleeding in the gastrointestinal tract, the prognosis is poor. After 3-7 days of incubation, fever, headache, fatigue, generalised muscle pain, nausea, vomiting, and skin and mucosal haemorrhages can occur [2]. J Microbiol Infect Dis 2016;6(1): 38-39 Key words: CCHF, endoscopy, gastrointestinal bleeding
Authors and Affiliations
Elif Börekçi, Mehmet Çelikbilek, Tuğba Özdemir, Çiğdem Kader, Hasan Börekçi
Development of Simplex-PCR Assays for Accurate Identification of Nine Staphylococcal Species at Genus and Species Levels
Development of Simplex-PCR Assays for Accurate Identification of Nine Staphylococcal Species at Genus and Species Levels Bibek Ranjan Shome1, Krithiga Natesan1, Susweta Das Mitra1,2, Nimita Venugopal1, Bhuvana Mani1, Fer...
şitme kaybı: Nörobruselloz olabilir mi?
Brusella, insanlara çoğunlukla enfekte yiyeceklerin yenmesiyle veya enfekte hayvan ile doğrudan temas yoluyla geçen bir zoonozdur. Her organ sistemini tutabilir ve buna bağlı olarak çok çeşitli klinik bulgularla ort...
Resistance patterns and trends of extensively drug-resistant tuberculosis: 5-year experience
Objective: Extensively drug-resistant tuberculosis (XDR-TB) strains were emerged when multidrug-resistant TB (MDR-TB) was inadequately treated. Inadequate treatment of MDR-TB cases may result in additional resistance esp...
Seroprevalence of Leptospira antibodies among populations at risk
Objective: This study was performed to assess the Leptospira IgG antibodies seroprevalence among populations at risk in Hodeida Governorate, Yemen. Methods: A total of 200 subjects (136 males and 64 females) participate...
Drug interaction of boceprevir and amlodipine in a patient with hepatitis C: A cardiovascular follow-up
Boceprevir is a NS3/4A hepatitis C virus (HCV) protease inhibitor, used in combination with peginterferon and ribavirin to treat HCV. Boceprevir undergoes extensive metabolism via cytochrome P450-mediated oxidation and...